Role of the vaginally administered aromatase inhibitor anastrozole in women with rectovaginal endometriosis: a pilot study

article OA: bronze CC0 ⤵ 70 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-10

This pilot study investigated the efficacy of vaginally administered anastrozole for treating rectovaginal endometriosis in women.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosisbowel_endometriosis

MeSH descriptors

Aromatase Inhibitors Endometriosis Nitriles Rectal Diseases Triazoles Vaginal Diseases Administration, Intravaginal Adult Anastrozole Aromatase Inhibitors Aromatase Inhibitors Chi-Square Distribution Endometriosis Endometriosis Female Humans Nitriles Nitriles Pilot Projects Rectal Diseases

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (26)

Cited by (50)

Source provenance

europepmc
last seen: 2026-07-04T06:08:07.471253+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:15:29.922408+00:00
License: CC0 · commercial use OK